MedTrace Logo

New Orleans Pulmonary Hypertension Biobank

NCT03269630 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2021-09-10

No results posted yet for this study

Summary

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.

Conditions

  • Pulmonary Hypertension
  • Systemic Sclerosis
  • Mixed Connective Tissue Disease
  • Heart Failure With Normal Ejection Fraction
  • Healthy

Interventions

OTHER

No intervention. Biospecimen collection only

Biospecimen collection

Sponsors & Collaborators

  • Louisiana State University Health Sciences Center in New Orleans

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-29
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03269630 on ClinicalTrials.gov